Increased systemic IL-6 levels indicate inflammation as a determinant component in renal cell carcinoma development

Authors

  • Giovana Cechim Universidade Federal do Rio Grande do Sul/UFRGS, Laboratório de Imunobiologia e Imunogenética, Programa de Pós-Graduação em Genética e Biologia Molecular (PPGBM), Departamento de Genética, Campus do Vale, Avenida Bento Gonçalves, 9500, Bairro Agronomia, 91501-970, Porto Alegre, RS, Brazil https://orcid.org/0000-0001-9249-5802
  • Joel Henrique Ellwanger Universidade Federal do Rio Grande do Sul/UFRGS, Laboratório de Imunobiologia e Imunogenética, Programa de Pós-Graduação em Genética e Biologia Molecular (PPGBM), Departamento de Genética, Campus do Vale, Avenida Bento Gonçalves, 9500, Bairro Agronomia, 91501-970, Porto Alegre, RS, Brazil https://orcid.org/0000-0002-1040-2738
  • Valéria de Lima Kaminski Universidade Federal do Rio Grande do Sul/UFRGS, Laboratório de Imunobiologia e Imunogenética, Programa de Pós-Graduação em Genética e Biologia Molecular (PPGBM), Departamento de Genética, Campus do Vale, Avenida Bento Gonçalves, 9500, Bairro Agronomia, 91501-970, Porto Alegre, RS, Brazil https://orcid.org/0000-0002-2731-0653
  • Milton Berger Hospital de Clínicas do Porto Alegre/HCPA, Departamento de Urologia, Rua Ramiro Barcelos, 2350, Bairro Santa Cecília, 90035-903, Porto Alegre, RS, Brazil https://orcid.org/0000-0001-6775-688X
  • José Artur Bogo Chies Universidade Federal do Rio Grande do Sul/UFRGS, Laboratório de Imunobiologia e Imunogenética, Programa de Pós-Graduação em Genética e Biologia Molecular (PPGBM), Departamento de Genética, Campus do Vale, Avenida Bento Gonçalves, 9500, Bairro Agronomia, 91501-970, Porto Alegre, RS, Brazil https://orcid.org/0000-0001-7025-0660

Keywords:

CBA, cytokines, IL-6, inflammation, renal cancer

Abstract

Introduction: Renal cell carcinoma (RCC) is one of the most prevalent kidney tumors. It is believed that inflammation is a key factor for cancer progression and spread since inflammatory markers are generally associated with poor prognosis in RCC patients. Cytokines are cell communication molecules that act in both healthy and pathological situations. Of note, the processes of tumor growth and progression are mediated by cytokines. Recent findings suggest that cytokine level measurements could be used for cancer monitoring and prognosis.

Methods: This study characterized and compared the systemic profile of different cytokines associated to the classical Th1, Th2 and Th17 immune responses in plasma samples from RCC patients (n=25) and healthy controls (n=29). Cytokine levels (IL-2, IL-4, IL-6, IL-10, TNF-α, IFN-γ, and IL-17A) were evaluated by flow cytometry using BD Cytometric Bead Array (CBA) kit.

Results: No statistical difference in systemic IL-2, IL-4, IL-10, IL-17A, TNF, and INF-γ levels were observed between RCC patients and controls (p>0.05). On the other hand, higher systemic IL-6 levels were observed in RCC patients in comparison to controls (p=0.0034).

Conclusions: This study highlights the importance of assessing the impact of IL-6 on RCC pathogenesis and its potential role as a biomarker of disease progression.

Downloads

Download data is not yet available.

Downloads

Published

2021-10-05

How to Cite

1.
Cechim G, Ellwanger JH, de Lima Kaminski V, Berger M, Bogo Chies JA. Increased systemic IL-6 levels indicate inflammation as a determinant component in renal cell carcinoma development. Clin Biomed Res [Internet]. 2021 Oct. 5 [cited 2025 Jun. 24];41(3). Available from: https://seer.ufrgs.br/index.php/hcpa/article/view/108350

Issue

Vol. 41 No. 3 (2021): Clinical and Biomedical Research

Section

Original Articles

License

Authors who publish with this journal agree to the following terms:

Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.

Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.

Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).